Establishments primarily engaged in: (1) manufacturing bulk organic and inorganic medicinal chemicals and their derivatives and (2) processing (grading, grinding, and milling) bulk botanical drugs and herbs. Included in this industry are establishments primarily engaged in manufacturing agar-agar and similar products of natural origin, endocrine products, manufacturing or isolating basic vitamins, and isolating active medicinal principals such as alkaloids from botanical drugs and herbs.
Adrenal derivatives: bulk, uncompounded
Agar-agar (ground)
Alkaloids and salts
Anesthetics, in bulk form
Antibiotics: bulk uncompounded
Atropine and derivatives
Barbituric acid and derivatives: bulk, uncompounded
Botanical products, medicinal: ground, graded, and milled
Brucine and derivatives
Caffeine and derivatives
Chemicals, medicinal: organic and inorganic bulk, uncompounded
Cinchona and derivatives
Cocaine and derivatives
Codeine and derivatives
Digitoxin
Drug grading, grinding, and milling
Endocrine products
Ephedrine and derivatives
Ergot alkaloids
Fish liver oils, refined and concentrated for medicinal use
Gland derivatives: bulk uncompounded
Glycosides
Herb grinding, grading, and milling
Hormones and derivatives
Insulin: bulk, uncompounded
Kelp plants
Mercury chlorides, U.S.P.
Mercury compounds, medicinal: organic and inorganic
Morphine and derivatives
Oils, vegetable and animal: medicinal grade refined and concentrated
Opium derivatives
Ox bile salts and derivatives: bulk, uncompounded
Penicillin: bulk, uncompounded
Physostigmine and derivatives
Pituitary gland derivatives: bulk, uncompounded
Procaine and derivatives: bulk, uncompounded
Quinine and derivatives
Reserpines
Salicylic acid derivatives, medicinal grade
Strychnine and derivatives
Sulfa drugs: bulk, uncompounded
Sulfonamides
Theobromine
Vegetable gelatin (agar-agar)
Vitamins, natural and synthetic: bulk, uncompounded
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Answeres comes easily with Industrius CFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine “what if scenarios and P&L impact of reducing costs or adding revenue.
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.